Yes, Phenylephrine is a Vasopressor
Phenylephrine is definitively a vasopressor—specifically an alpha-1 adrenergic receptor agonist used to increase blood pressure in adults with clinically important hypotension resulting primarily from vasodilation, including septic shock and anesthesia-induced hypotension 1.
Mechanism and Classification
Phenylephrine functions as a selective α1-receptor agonist that increases blood pressure primarily through vasoconstriction 2. Unlike mixed-action vasopressors such as norepinephrine or epinephrine, phenylephrine has no direct inotropic effects on the heart 3. This pure vasoconstrictive action distinguishes it from other catecholamine vasopressors that have both alpha and beta-adrenergic activity 4.
FDA-Approved Indications
The FDA explicitly approves phenylephrine for:
- Increasing blood pressure in adults with clinically important hypotension
- Vasodilation-related hypotension in settings such as septic shock
- Anesthesia-induced hypotension 1
Clinical Dosing
For perioperative hypotension:
- IV bolus: 50-250 mcg
- Continuous infusion: 0.5-1.4 mcg/kg/min titrated to effect
For vasodilatory shock:
- Continuous infusion: 0.5-6 mcg/kg/min titrated to effect 1
Important Clinical Considerations
Cardiovascular Effects
Phenylephrine can cause reflex bradycardia and decreased cardiac output due to increased afterload without direct cardiac stimulation 1. However, in preload-dependent patients (such as those under general anesthesia with reduced sympathetic tone), phenylephrine can paradoxically increase cardiac output by recruiting venous return and restoring preload 3.
Safety Profile
- Peripheral administration is safe when used in moderate doses for short durations (mean maximum 79 mcg/min for ~19 hours), with only 3% infiltration rate and no significant tissue injury 5
- Risk of extravasation causing tissue necrosis exists, though may be overestimated given its modest potency 5
- Contains sulfites, which may cause allergic-type reactions 1
Limitations in Septic Shock
Critical caveat: Recent evidence shows phenylephrine use in septic shock is associated with increased mortality (56% vs 41%, p=0.003), particularly in patients with ongoing tachycardia (54% vs 36%, p=0.02) 2. This aligns with current guidelines recommending limited utilization of phenylephrine in septic shock due to lack of supporting evidence 2. Norepinephrine remains the preferred first-line vasopressor for septic shock 4, 6.
Preferred Use Cases
Phenylephrine is most appropriately used for: